Specialists in nephrology, dialysis, diabetology, cardiology, neurology, rehabilitation, and diagnostics.
NefroCenter is Italy’s leading private group specializing in nephrology, dialysis, and diabetology, while also offering expertise in cardiology, neurology, rehabilitation, imaging diagnostics, laboratory diagnostics, molecular biology, and genetics. With services provided in partnership with the National Health Service (SSN), NefroCenter is committed to delivering exceptional healthcare through a team of specialists using state-of-the-art technologies, ensuring efficient and high-quality patient care.
In 2016, NefroCenter launched significant research initiatives in collaboration with Federico II University, the University of Campania “Luigi Vanvitelli,” and La Sapienza University in Rome, founding NefroCenter Research
By the end of 2018, NefroCenter expanded into the pharmaceutical sector with the acquisition of LA.FA.RE srl.
In 2023, NefroCenter further strengthened its presence by acquiring the Rome American Hospital (RAH) and RSA Longoni, two healthcare facilities in Rome with a combined capacity of 292 beds. This includes 160 beds at RAH (with 10 dedicated to intensive care and coronary care), 24 dialysis stations (SSN-accredited), and 108 beds at RSA, featuring 18 semi-residential beds and Integrated Home Care (ADI), all accredited with the SSN.
In 2024, three private clinics joined the NefroCenter group: Villa Arbe in Milan, Villa Annamaria in Rome and Santa Rita di Atripalda in the province of Avellino.
NefroCenterDialysis
Centers of Excellence for Nephrology and Dialysis
NefroCenter Diabetology
Centers for Diagnosis and Treatment of Diabetes
NefroCenterLab
Clinical analysis laboratories authorized for COVID-19 testing
NefroCenter Diagnostics
State-of-the-art instrumental diagnostics
NefroCenterCardio
Prevention and management of cardiovascular diseases
NefroCenter Neurodiagnostics
Diagnosis and treatment of neurological disorders
NefroCenter Research
Today's science is tomorrow's technology
NefroCenter Pharma
Pharmaceutical research and production
Rome American Hospital - RAH
A multi-specialty hospital facility in Rome
RSA Longoni & ADI
Specialists in continuous care for disabled individuals, the elderly, minors, and their families
Clinica Santa Rita
A multi-specialty hospital facility in Atripalda (Avellino)
Casa di Cura Villa Anna Maria
A multi-specialty hospital facility in Rome
Clinica Villa Arbe
Structure with focus on medicine and cosmetic surgery in Milan
La Farmacia del Sole
Cutting-edge medications and consultancy at all levels
Patient Services
At NefroCenter, our team’s professionalism and extensive experience allow us to provide comprehensive support to patients throughout their therapy. With state-of-the-art medical equipment, we ensure the highest quality care at every stage of treatment. Our mission is to deliver exceptional healthcare services that meet the unique needs of patients in nephrology, dialysis, and diabetology, as well as in cardiology, neurology, rehabilitation, imaging diagnostics, laboratory diagnostics, molecular biology, and genetics.
Dialysis
The dialysis centers of the Nefrocenter group provide all types of treatments, allowing patients to receive high-level care with state-of-the-art technology, including the use of the latest generation of artificial kidneys.
Diabetology
Nefrocenter outpatient clinics enable rapid diagnosis of diseases in diabetic patients. With our specialists, it is possible to prevent and assess the cardiologic, neurologic, angiologic, nephrologic, ophthalmologic, and podiatric complications that may arise.
Instrumental Diagnostics
Nefrocenter radiology centers are equipped with innovative instrumentation capable of performing a wide range of diagnostic imaging examinations, providing high-quality images while reducing the risk of radiation exposure. A rapid reporting service and highly qualified personnel support the patient throughout the diagnostic process.
Cardiology
Nefrocenter’s cardiology centers are equipped with the highest standards for the care and prevention of all cardiovascular, cardio-nephrological, and diabetological conditions. The centers also perform a comprehensive range of instrumental cardiac examinations.
Laboratory Diagnostics
Maiello Laboratory in Naples, Toma Centro Sud and Miglio d’Oro Laboratory in Ercolano stand out for the quality and comprehensiveness of their specialized investigations, performing over 1000 tests, ranging from routine analyses to cutting-edge investigations such as Medical Genetics and Molecular Biology. The primary objective of these laboratories is to provide highly qualified analysis services to all patients of the Nefrocenter group, as well as to the general public.
These centers are authorized to perform the main serological COVID-19 tests. Additionally, Maiello Laboratory has been included among the reference laboratories in the Campania region for the examination of oropharyngeal swabs for COVID-19, supporting public hospital facilities.
Hyperbaric Therapy Rehabilitation
Neuromotor rehabilitation activities are aimed at functional recovery for patients with neurological and orthopedic conditions. Among the prominent treatments, Nefrocenter also offers services such as instrumental physiotherapy, hydrokinesitherapy, and hyperbaric oxygen therapy. These services play a significant role in the comprehensive rehabilitation and overall well-being of patients.
Neurology
The Vaia Neurodiagnostic Institute – Nefrocenter, operating with 8 different specialized clinics, provides highly quality services in the field of neurology, neurodiagnostics, and neurorehabilitation for central and peripheral neurological conditions.
Dermatology
In the centers of the Nefrocenter group, dermatological screening with a specialist visit is conducted. The diagnostic examination for dynamic mapping of moles is performed using the Body Scan System and can also be done remotely, thanks to new technological systems.
Risk management and adverse events
At the centers, no adverse events occurred in the year 2020 and in the last five years. The centers are committed to publishing data regarding any compensations in the event of harmful incidents to the health and safety of patients attributable to the dialysis centers.
This report has been prepared in accordance with the provisions of Law No. 24 of 2017, Article 5.